PARISI, SAVERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.471
EU - Europa 869
AS - Asia 512
OC - Oceania 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 8.863
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.458
IT - Italia 322
CN - Cina 298
FI - Finlandia 141
SG - Singapore 136
DE - Germania 112
SE - Svezia 100
UA - Ucraina 100
GB - Regno Unito 59
VN - Vietnam 49
FR - Francia 17
IN - India 11
HK - Hong Kong 10
IE - Irlanda 10
CA - Canada 8
MX - Messico 5
AU - Australia 3
BR - Brasile 3
ES - Italia 3
KH - Cambogia 3
NL - Olanda 3
BE - Belgio 2
EU - Europa 2
TR - Turchia 2
AR - Argentina 1
BD - Bangladesh 1
EG - Egitto 1
IQ - Iraq 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 8.863
Salva come PNG Salva come JPEG
Città #
Fairfield 1.307
Woodbridge 837
Chandler 696
Houston 587
Ashburn 521
Ann Arbor 433
Seattle 429
Cambridge 421
Wilmington 419
Jacksonville 408
Princeton 194
San Diego 166
Padova 110
Roxbury 97
Singapore 83
Medford 81
Boardman 64
Helsinki 58
Beijing 52
Dong Ket 48
Nanjing 47
Des Moines 46
Guangzhou 32
New York 24
Nanchang 23
Rome 18
London 16
Shenyang 16
Hebei 15
Aprilia 14
Norwalk 13
Ogden 13
Jiaxing 12
Falls Church 11
Dublin 10
Los Angeles 10
Redwood City 10
Hefei 9
Burolo 8
Hong Kong 8
Jinan 8
Kunming 8
Milan 8
Kharkiv 7
Paris 7
Tianjin 7
Changsha 6
Medicina 6
Ningbo 6
Santa Cruz 6
Shanghai 6
Borås 5
Kilburn 5
Lappeenranta 5
Orange 5
Washington 5
Auburn Hills 4
Bergamo 4
Ottawa 4
Chicago 3
Dearborn 3
Florence 3
Frederick 3
Lenna 3
Perth 3
Pietro 3
Redmond 3
Zhengzhou 3
Afragola 2
Altavilla 2
Ankara 2
Arce 2
Buffalo 2
Campobasso 2
Camponogara 2
Chiampo 2
Columbus 2
Dallas 2
Due Carrare 2
Ghent 2
Gunzenhausen 2
Haikou 2
Indiana 2
Lanzhou 2
Naples 2
Phoenix 2
Pianiga 2
Porto Garibaldi 2
Prescot 2
Pune 2
Richland 2
Rivoli 2
Rovigo 2
San Martino Buon Albergo 2
San Polo di Piave 2
Swansea 2
São Paulo 2
Taiyuan 2
Taizhou 2
Verona 2
Totale 7.569
Salva come PNG Salva come JPEG
Nome #
Viral infections of the central nervous system in elderly patients: A retrospective study 171
Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy. 163
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo' 157
Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection 149
Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: Complexity and vaccine implications 146
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 143
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 138
Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014 135
Simple determination of the HIV protease inhibitor atazanavir in human plasma by high-performance liquid chromatography with UV detection 132
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 126
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 124
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma 123
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 122
KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection. 118
Clustering and Risk Factors of Methicillin-Resistant Staphylococcus aureus Carriage in Two Italian Long-Term Care Facilities 118
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 117
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 116
Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data. 114
Virological testing of cerebrospinal fluid in children aged less than 14 years with a suspected central nervous system infection: A retrospective study on 304 consecutive children from January 2012 to May 2015 113
Transfer of KPC-2 Carbapenemase from Klebsiella pneumoniae to Escherichia coli in a Patient: First Case in Europe 106
Detection of an early HIV-1 infection by HIV RNA testing in an Italian blood donor during the preseroconversion window period 106
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens 105
Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: A 24-month longitudinal study 105
Clustering and Risk Factors of Methicillin-Resistant Staphylococcus aureus Carriage in Two Italian Long-Term Care Facilities. 103
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV. 103
Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection 102
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients 98
Deep neck abscesses due to Acinetobacter baumanii infection. 97
Human immunodeficiency virus polymorphisms and zidovudine resistance 96
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 95
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 93
Distribution of the CCR5 Delta 32 allele in Italian HIV type 1-infected and normal individuals 92
Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients. 91
Prevalence, molecular epidemiology and intra-hospital acquisition of Klebsiella pneumoniae strains producing carbapenemases in an Italian teaching hospital from January 2015 to September 2016. 91
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 90
Agenesis of the corpus callosum, combined immunodeficiency, bilateral cataract, and hypopigmentation in two brothers. 90
Legal scenarios in the coronavirus time: Medico legal implications in the aspects of governance 90
Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy. 88
Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004–2012 in the Veneto Region, Italy 87
null 87
Drug-resistance mutations can be archived very early in HIV primary infection 87
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients 86
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 86
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy 84
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 84
Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients 84
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 83
Long-term therapy with nevirapine and tropism 83
Rational Diagnostic and therapeutic management of deep neck infections. Analysis of 233 consecutive cases 83
Unboosted fosamprenavir is associated with low drug exposure in hiv-infected patients with mild-moderate liver impairment for hcv-related cirrhosis. 82
HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection 81
Infections in liver and lung transplant recipients: A national prospective cohort 80
Association between cellular human immunodeficiency virus DNA level andimmunological parameters in patients with undetectable plasma viremia levelduring highly active antiretroviral therapy. 80
Primary human herpesvirus 8 infection in immunocompetent children 79
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS 79
Molecular epidemiology of Enterococcus faecium isolates from an Italian hospital 79
Switching of Inferred Tropism Caused by HIV during Interruption of Antiretroviral Therapy 78
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group 77
Human immunodeficiency virus infection of human bone marrow stromal myoid cells 76
Detection of hepatitis C virus in an exhumed body identified the origin of a nosocomial transmission that caused multiple fatal diseases 75
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients 74
Biological phenotype, replicative capacity and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 73
Sustained Virological Response and Baseline Predictors in HIV-HCV Coinfected Patients Retreated with Pegylated Interferon and Ribavirin after Failing a Previous Interferon-Based Therapy: Systematic Review and Meta-Analysis 73
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects 73
Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. 70
Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach 68
Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1–HCV co-infected patients on effective combined anti-HIV treatment 68
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 67
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 67
Virological efficacy of abacavir: systematic review and meta-analysis 67
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy 67
HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective. 66
Anti-HIV gene therapy strategies combining multiple siRNA with the entry inhibitor 65
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load during different antiretroviral regimens. 63
EFFICIENT AND REPRODUCIBLE NEW SEMIMICROMETHOD FOR THE DETECTION AND TITRATION OF HIV IN HUMAN PLASMA 61
HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study 60
Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells 60
Intra-hospital acquisition of colonization and infection by Klebsiella pneumoniae strains producing carbapenemases and carriage evolution: A longitudinal analysis in an Italian teaching hospital from January 2017 to August 2019 56
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013–2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors 55
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals 54
Rome consensus conference - statement; human papilloma virus diseases in males 54
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 52
Cellular proviral HIV-DNA decline and viral isolation in naive subjects with < 5000 copies/ml of HIV-RNA and > 500 x 10(6)/I CD4 cells treated with highly active antiretroviral therapy 51
Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals 48
Transmission of human herpesvirus 8 by blood transfusion 48
Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ (Nature, (2020), 584, 7821, (425-429), 10.1038/s41586-020-2488-1) 48
HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. 47
Le attività di sorveglianza di laboratorio delle infezioni batteriche invasive nella Regione Veneto (anno 2007) 46
HIV-1 reverse transcriptase M184V and R212 K combined mutations conconfer phenotypic resistance to stavudine 42
HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection 42
Evaluation of the Uro4 HB&L™ system for the rapid diagnosis of lower respiratory tract infections in intensive care units 41
Sustained virological response after treatment with direct-acting antivirals can help immune reconstitution in HIV-HCV coinfected patients even in case of persistent HIV low-level viremia 41
[Oculocutaneous albinism and tyrosinuria. Description of a clinical case]. 40
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment. 39
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 36
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. 35
Switching of HIV inferred tropism during interruption of antiretroviral therapy 34
Viral molecular testing of cerebrospinal fluid in adults with suspected central nervous system infection in an italian university hospital laboratory: A retrospective study on 1462 consecutive patients 33
Time Course of Neutralizing Antibody in Health Care Workers with Mild or Asymptomatic COVID-19 Infection 33
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 33
Totale 8.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.440
article - articoli 37.010
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 132
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.641 0 66 34 191 195 151 194 224 248 160 94 84
2020/20211.489 85 122 72 142 89 110 72 170 215 95 192 125
2021/20221.751 45 163 165 88 63 71 82 154 208 76 234 402
2022/20231.293 312 141 66 126 206 129 7 86 140 11 58 11
2023/2024711 25 91 94 74 47 69 62 40 24 33 67 85
2024/202523 18 5 0 0 0 0 0 0 0 0 0 0
Totale 9.023